title: Intralesional therapy for psoriasis.
abstract: Localized resistant plaques of psoriasis often remain despite highly effective anti-psoriasis treatment. Intralesional therapy is often used to treat various malignant, infectious or inflammatory cutaneous diseases, including psoriasis. Despite the presence of many review articles on the treatment of psoriasis, no articles exist which review the use of intralesional therapy for psoriasis. In this article, we review the published literatures of intralesional therapy for psoriasis. Corticosteroids, methotrexate, cyclosporin, biologics, botulinum toxin type-A, 15-hydroxyeicosatetraenoic acid, and chemotherapy agents such as 5-fluorouracil are discussed. Also, agents which may be used intralesionally and have the potential to treat psoriasis will also be reviewed such as bleomycin, vincristine or vinblastine, mitomycin-C, aminophylline, 5-aminolevulinic acid, rituximab, bevacizumab and pentoxifylline are included.
authors.affiliation: Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan, Republic of China.
authors.forename: Ting-Shun
authors.initials: TS
authors.lastname: Wang
authors.forename: Tsen-Fang
authors.initials: TF
authors.lastname: Tsai
mesh_terms: D003879:Dermatologic Agents / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D003879:Dermatologic Agents